Tag: Diffusion Pharmaceuticals
Diffusion Pharmaceuticals anticipates coronavirus will slow enrolment in its ambulance-based stroke...
Diffusion Pharmaceuticals has announced that it expect delays in enrolment in the company’s ambulance-based PHAST-TSC phase 2 clinical trial in acute stroke due to...
Innovative on-ambulance PHAST-TSC trial for treatment of acute stroke approved by...
Diffusion Pharmaceuticals, a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where...
